UnitedHealth Group, US91324P1021

Mizuho lifts target to USD 500 for UnitedHealth Group stock

Published on 10/26/2026 at 12:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UnitedHealth Group stock costs EUR 374.90 on October 26, 2026. It sits below EUR 378.60, while third-quarter revenue reached USD 112.70 billion.

Target changes and quarterly figures

  • Mizuho Securities moved its target from USD 493.00 to USD 500.00 on October 22, 2026.
  • Third-quarter revenue reached USD 112.70 billion and adjusted earnings per share reached USD 4.69.
  • UnitedHealth Group stock trades at EUR 374.90 at 12:09 p.m. CET at Lang & Schwarz on October 26, 2026, 0.98 percent below the Xetra close of October 23, 2026.
  • RBC Capital raised its target from USD 478.00 to USD 498.00 on October 20, 2026.
UnitedHealth Group US91324P1021 im Bauhaus-Stil mit geometrischen Formen Primärfarben und abstrakten Menschenfiguren, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) stood at EUR 374.90 at Lang & Schwarz on October 26, 2026 at 12:09 p.m. CET, 0.98 percent below the Xetra close of October 23, 2026 at EUR 378.60. On October 22, 2026, Mizuho Securities maintained its Buy rating and raised its target from USD 493.00 to USD 500.00, according to Futu News.

What changed in the third quarter?

UnitedHealth reported third-quarter 2026 revenue of USD 112.70 billion, operating earnings of USD 6.60 billion and adjusted earnings per share of USD 4.69. The company also lifted its full-year 2026 adjusted earnings outlook to at least USD 20.50 per share. Those figures came from the company's October 13 release, which also put the quarter's net margin at 3.60 percent, according to UnitedHealth Group.

The earnings comparison was favorable on an adjusted basis. UnitedHealth earned USD 4.69 per share against a USD 4.14 consensus estimate, while its medical cost ratio was 88.40 percent, below the 89.90 percent recorded a year earlier, Reuters reported on October 13, 2026.

Three dated moves in October

Chronology places the main developments in sequence. On October 13, 2026, UnitedHealth reported USD 112.70 billion in third-quarter revenue and adjusted earnings of USD 4.69 per share, as detailed by Reuters. On October 20, 2026, RBC Capital raised its target from USD 478.00 to USD 498.00 while keeping an Outperform rating, according to Markets Insider. On October 22, 2026, Mizuho raised its target from USD 493.00 to USD 500.00.

What does the target change mean?

The analyst picture is split. Baird cut its target from USD 453.00 to USD 427.00 on October 14, 2026, while RBC and Mizuho subsequently moved their targets higher. The contrast reflects a debate over whether lower medical-cost pressure and Optum execution can offset elevated healthcare costs and membership changes.

Stock stays below the Xetra close

UnitedHealth Group's euro quotation was EUR 374.90 at Lang & Schwarz on October 26, 2026 at 12:09 p.m. CET, 0.98 percent below the Xetra close of October 23, 2026 at EUR 378.60. Its market capitalization was EUR 336.1 billion as of October 26, 2026, and the 52-week range was EUR 222.70 to EUR 400.60.

The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.

UnitedHealth Group at a glance

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • Ticker: UNH
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 26, 2026, 12:09 p.m. CET): EUR 374.90
  • Change versus Xetra close: minus 0.98 percent
  • Xetra close (October 23, 2026): EUR 378.60
  • Market capitalization: EUR 336.1 billion (as of October 26, 2026)
  • 52-week range: EUR 222.70-400.60 (as of October 26, 2026)
  • Sector / Industry: Healthcare / Medical - Healthcare Plans

Market context: Market report S&P 500.

More news and analyses on UnitedHealth Group stock

Disclaimer...
en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 70414295 | bgmi